Fundraising Fox

Genvax

Ames, US · 2 known investors

genvax.com

Genvax Technologies develops mRNA and nanoparticle-based vaccines for livestock, focusing on custom, herd-specific formulations that aim to improve speed and precision compared to conventional vaccine platforms. The company serves animal health and food supply sectors.

AgTechBiotechHealthtechin /genvax@GenvaxTech

Founders & leadership

JH
Joel HarrisinCo-founder
DH
Dr. Hank HarrisCo-founder
DH
DL Hank HarrisDirector
SH
Scott HolmstromDirector

Investors · 2

Reported raises · per SEC filings

Form D private placements
$3.4MraisedJun 2024 · 9 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Joel HarrisExecutive Officer, Director
  • Trent TorranceDirector
  • DL Hank HarrisDirector
Offering amount
$5.2M
Amount sold
$3.4M
First sale
Jun 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$6.4MraisedAug 2022 · 20 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • DL Hank HarrisDirector
  • Scott HolmstromDirector
  • Joel HarrisExecutive Officer, Director
Offering amount
$6.4M
Amount sold
$6.4M
First sale
Jun 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.